Adjucanta Mab Approval

3min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

Biogen's adjucanta mab was approved for use by patients in the U.S. This is not how things are usually done, says John Defterios. The thinking behind those decisions is, here are people who are facing a terminal illness. What's the harm in letting them try something that might have a benefit for them?

For decades, Alzheimer’s researchers have been stubbornly pursuing a single theory, but they’re starting to wonder: is this narrow focus the reason we still don’t have a cure?

For more, go to http://vox.com/unexplainable

It’s a great place to sign up for our newsletter, view show transcripts, and read more about the topics on our show.

Also, email us! unexplainable@vox.com

We read every email.

Support Unexplainable by making a financial contribution to Vox! bit.ly/givepodcasts

Learn more about your ad choices. Visit podcastchoices.com/adchoices